Breast Cancer: Chaired by Sara A. Hurvitz, MD

Video

In Partnership With:

Early detection, personalized treatment approaches, and increased situational awareness have improved cancer patient survival rates. Ongoing dialogue among leading experts can only improve patient outcomes and advance the field of breast cancer.

Breast Cancer: Chaired by Sara A. Hurvitz, MD

The live filming of this virtual event in our IPC series is now on-demand.

Early detection, personalized treatment approaches, and increased situational awareness have improved cancer patient survival rates. Ongoing dialogue among leading experts can only improve patient outcomes and advance the field of breast cancer.

Speakers:

  • Sara A. Hurvitz, MD | UCLA Jonsson Comprehensive Cancer Center
  • William J. Gradishar, MD | Northwestern University Feinberg School of Medicine
  • Ruth O’Regan, MD | University of Rochester
  • Aditya Bardia, MD, MPH | Massachusetts General Hospital, Harvard Medical School

Topics:

  • Gauging When Enough is Enough for Early Stage Disease
  • CDK4/6i in the Adjuvant Setting
  • HR+/HER2- MBC Updates
  • The Data is Not All Negative in Triple Negative Disease
Related Videos
Gottfried Konecny, MD
Karim Chamie, MD, associate professor, urology, the University of California, Los Angeles
Richard Finn, MD, and David James Pinato, MD, MRCP, PhD, experts on hepatocellular carcinoma
Richard Finn, MD, and David James Pinato, MD, MRCP, PhD, experts on hepatocellular carcinoma
Richard Finn, MD, and David James Pinato, MD, MRCP, PhD, experts on hepatocellular carcinoma
Richard Finn, MD, and David James Pinato, MD, MRCP, PhD, experts on hepatocellular carcinoma
Deborah J. Wong, MD, PhD
Michael Richardson, MD
Gottfried E. Konecny, MD, lead clinician, gynecologic oncology, Department of Medicine, the University of California, Los Angeles
Kelly E. McCann, MD, PhD